Literature DB >> 1308664

Herpes zoster and human immunodeficiency virus infection.

S P Buchbinder1, M H Katz, N A Hessol, J Y Liu, P M O'Malley, R Underwood, S D Holmberg.   

Abstract

The interaction of herpes zoster and the human immunodeficiency virus (HIV) was evaluated in a cohort study of 287 homosexual men with well-defined dates of HIV seroconversion and 499 HIV-seronegative homosexual men. The incidence of herpes zoster was significantly higher among HIV-seropositive men (29.4 cases/1000 person-years) than among HIV-seronegative men (2.0 cases/1000 person-years); the overall age-adjusted relative risk (RR) was 16.9 (95% confidence interval [CI], 8.7-32.6). When compared with that of age-matched population controls from 1945 to 1959, the incidence of zoster was significantly higher among seropositive men (RR, 26.7; 95% CI, 19.3-37.1) and slightly higher among seronegative men (RR, 1.85; 95% CI, 1.0-3.3); the latter may reflect increasing background rates over several decades. The risk of herpes zoster was not associated with duration of HIV infection and was not predictive of faster progression to AIDS.

Entities:  

Mesh:

Year:  1992        PMID: 1308664     DOI: 10.1093/infdis/166.5.1153

Source DB:  PubMed          Journal:  J Infect Dis        ISSN: 0022-1899            Impact factor:   5.226


  72 in total

1.  HIV INFECTION IN HERPES ZOSTER.

Authors:  Plk DE Sylva; K M Shah; H Mani; A K Hukkoo; S Bhattacharya; Yogesh Chander
Journal:  Med J Armed Forces India       Date:  2017-06-26

2.  Incidence and predictors of herpes zoster among antiretroviral therapy-naïve patients initiating HIV treatment in Johannesburg, South Africa.

Authors:  Kate Shearer; Mhairi Maskew; Toyin Ajayi; Rebecca Berhanu; Pappie Majuba; Ian Sanne; Matthew P Fox
Journal:  Int J Infect Dis       Date:  2014-03-25       Impact factor: 3.623

Review 3.  Update on opportunistic infections in the era of effective antiretroviral therapy.

Authors:  Brian C Zanoni; Rajesh T Gandhi
Journal:  Infect Dis Clin North Am       Date:  2014-09       Impact factor: 5.982

4.  Impact of Antiretroviral Therapy on the Risk of Herpes Zoster among Human Immunodeficiency Virus-Infected Individuals in Tanzania.

Authors:  Kosuke Kawai; Claudia A Hawkins; Ellen Hertzmark; Joel M Francis; David Sando; Aisa N Muya; Nzovu Ulenga; Wafaie W Fawzi
Journal:  Am J Trop Med Hyg       Date:  2018-01-04       Impact factor: 2.345

5.  Influence of age and nature of primary infection on varicella-zoster virus-specific cell-mediated immune responses.

Authors:  Adriana Weinberg; Ann A Lazar; Gary O Zerbe; Anthony R Hayward; Ivan S F Chan; Rupert Vessey; Jeffrey L Silber; Rob R MacGregor; Kenny Chan; Anne A Gershon; Myron J Levin
Journal:  J Infect Dis       Date:  2010-04-01       Impact factor: 5.226

Review 6.  Chickenpox, chickenpox vaccination, and shingles.

Authors:  P D Welsby
Journal:  Postgrad Med J       Date:  2006-05       Impact factor: 2.401

Review 7.  HIV-Related Skin Disease in the Era of Antiretroviral Therapy: Recognition and Management.

Authors:  Khatiya Chelidze; Cristina Thomas; Aileen Yenting Chang; Esther Ellen Freeman
Journal:  Am J Clin Dermatol       Date:  2019-06       Impact factor: 7.403

8.  Presentation and management of herpes zoster (shingles) in the geriatric population.

Authors:  Kenneth R Cohen; Rebecca L Salbu; Jerry Frank; Igor Israel
Journal:  P T       Date:  2013-04

9.  Reactivation of Simian Varicella Virus in Rhesus Macaques after CD4 T Cell Depletion.

Authors:  Vicki Traina-Dorge; Brent E Palmer; Colin Coleman; Meredith Hunter; Amy Frieman; Anah Gilmore; Karen Altrock; Lara Doyle-Meyers; Maria A Nagel; Ravi Mahalingam
Journal:  J Virol       Date:  2019-01-17       Impact factor: 5.103

Review 10.  Microbiology laboratory and the management of mother-child varicella-zoster virus infection.

Authors:  Massimo De Paschale; Pierangelo Clerici
Journal:  World J Virol       Date:  2016-08-12
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.